WHO ICTRP trial
Studies to examine the best tumor reduction rate for predicting the pCR after…
JPRN-UMIN000015224 · Japan Primary Registries Network (JPRN) · Not Recruiting
Key facts
| Trial ID | JPRN-UMIN000015224 |
|---|---|
| Public title | Studies to examine the best tumor reduction rate for predicting the pCR after two cycles docetaxel chemotherapy breast preoperative |
| Scientific title | Studies to examine the best tumor reduction rate for predicting the pCR after two cycles docetaxel chemotherapy breast preoperative - Studies to examine the best tumor reduction rate for predicting the pCR after two cycles docetaxel chemotherapy breast preoperative |
| Primary sponsor | Nagasaki University Hospital |
| Registry | Japan Primary Registries Network (JPRN) |
| Recruitment status | Not Recruiting |
| Study type | Interventional |
| Phase | Not selected |
| Countries | Japan |
| Conditions | Invasive breast cancer |
| Interventions | And chemotherapy two cycles enforcement preoperative, performing a therapeutic effect judgment. If the disease has progressed obviously, to stop the treatment. |
| Registration date | Jan 10, 2014 |
| Target size | 60 |
| Registry page | center6.umin.ac.jp |
At a glance
- No Results available
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About WHO ICTRP trial registrations
The WHO ICTRP combines trial registrations from primary registries worldwide into a single searchable index. Contact and ethics-committee details are not shown here.
Source: World Health Organization (WHO), International Clinical Trials Registry Platform (ICTRP) · Source date: